Zimmer Biomet Holdings Inc
Fechado
SetorSaúde
89.97 2.76
Visão Geral
Variação de preço das ações
24h
Mín
87.54
Máximo
90.5
Rendimento | 99M 239M |
|---|---|
Vendas | -157M 2.1B |
P/E Médio do Setor | 22.797 50.958 |
EPS | 2.09 |
Rendimento de Dividendos | 1.1 |
Margem de lucro | 11.43 |
Funcionários | 17,000 |
EBITDA | 84M 538M |
Recomendações | Neutro |
|---|---|
Previsão para 12 meses | +7.02% upside |
Rendimento de Dividendos Médio do Setor | 1.10% 2.41% |
|---|---|
Próximos Ganhos | 6 de ago. de 2026 |
Próxima data de dividendos | 31 de jul. de 2026 |
Próxima data de ex-dividendo | 25 de jun. de 2026 |
Capitalização de Mercado | -899M 17B |
|---|---|
Abertura anterior | 87.21 |
Fecho anterior | 89.97 |
Sentimento de Notícias
By Acuity
50%
50%
146 / 342 Ranking em Healthcare
Zimmer Biomet Holdings Inc Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.